Top

Published in:

01-02-2009 | Basic Neurosciences, Genetics and Immunology - Original Article

A functional dopamine-β-hydroxylase gene promoter polymorphism is associated with impulsive personality styles, but not with affective disorders

Authors: C. Hess, A. Reif, A. Strobel, A. Boreatti-Hümmer, M. Heine, K.-P. Lesch, C. P. Jacob

Published in: Journal of Neural Transmission | Issue 2/2009

Abstract

Dopamine-β-hydroxylase (DβH) catalyzes the conversion of dopamine to norepinephrine in central noradrenergic and adrenergic neurons and thus is critically involved in the biosynthesis of catecholamines. There are equivocal findings concerning the question whether or not DßH activity levels are altered in affective disorders or in subtypes of affective disorders. Moreover, information about the role of dopamine beta-hydroxylase (DBH) genotype, which explains a large part of the variance of enzymatic activity, in affective disorders and personality dimensions is limited. To resolve these inconsistencies, association tests were performed using four independent samples, healthy volunteers (N = 387), patients with affective disorders (N = 182), adult attention deficit hyperactivity disorder (ADHD) patients (N = 407), and patients with personality disorders (N = 637). In the latter two samples, the revised NEO personality inventory (NEO-PI-R) was administered. All participants were genotyped for a putatively functional single nucleotide polymorphism (C-1021T, rs1611115). No differences in DBH C-1021T genotype distribution were observed between patients with affective disorders and healthy control subjects. Also when the patient sample was divided into uni- and bipolar patients versus controls, no significant differences emerged. Furthermore, no clear-cut association was detected between the TT genotype and personality disorder clusters while there was a significant association with adult ADHD. However, personality disorder patients carrying the DBH TT genotype exhibited higher neuroticism and novelty seeking scores as compared to individuals with the CC or CT genotype. Analyses on the level of the neuroticism and novelty seeking subscales revealed that the DBH TT genotype was primarily associated with personality features related to impulsiveness and aggressive hostility. Also adult ADHD patients carrying the homozygous TT genotypes displayed by significantly increased neuroticism scores; when both personality disorder and adult ADHD patient were analyzed together, TT carriers also displayed by significantly lower conscientiousness levels. Our results thus do not implicate the DBH C-1021T polymorphism in the pathophysiology of depressive disorders or personality disorders, yet homozygosity at this locus appears to increase the risk towards personality traits related to impulsiveness, aggression and related disease states, namely adult ADHD. These data argue for a dimensional rather than categorical effect of genetic variance in DBH activity; accordingly, the inconsistency of previous findings concerning DβH levels in affective disorders might be caused by the underlying association of the TT genotype at DBH-1021 with impulsive personality traits.

Arbeitsgemeinschaft für Methodik und Dokumentation in der Psychiatrie (2000) Das AMDP-System. Manual zur Dokumentation psychiatrischer Befunde, 7th edn. Hogrefe, Goettingen

Arnsten AF, Li BM (2005) Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions. Biol Psychiatry 57:1377–1384PubMedCrossRef

Bhaduri N, Mukhopadhyay K (2006) Lack of significant association between -1021C → T polymorphism in the dopamine beta hydroxylase gene and attention deficit hyperactivity disorder. Neurosci Lett 402:12–16PubMedCrossRef

Brozoski TJ, Brown RM, Rosvold HE, Goldman PS (1979) Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science 205:929–932PubMedCrossRef

Cloninger CR, Przybeck TR, Svrakic DM (1991) The Tridimensional Personality Questionnaire: U.S. normative data. Psychol Rep 69:1047–1057PubMedCrossRef

Coccaro EF, Lee R, McCloskey M (2003) Norepinephrine function in personality disorder: plasma free MHPG correlates inversely with life history of aggression. CNS Spectr 8:731–736PubMed

Collier DA, Stöber G, Li T, Heils A, Catalano M, Di Bella D et al (1996) A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. Mol Psychiatry 1:453–460PubMed

Cohen J (1988) Statistical power analysis for the behavioral sciences, 2nd edn. Lawrence Erlbaum Associates, Hillsdale

Costa PT Jr, McCrae RR (1995) Domains and facets: hierarchical personality assessment using the revised NEO personality inventory. J Pers Assess 64:21–50PubMedCrossRef

Craig SP, Buckle VJ, Lamouroux A, Mallet J, Craig IW (1988) Localization of the human dopamine beta hydroxylase (DBH) gene to chromosome 9q34. Cytogenet Cell Genet 48:48–50PubMedCrossRef

Cubells JF, Zabetian CP (2004) Human genetics of plasma dopamine beta-hydroxylase activity: applications to research in psychiatry and neurology. Psychopharmacology (Berl) 174:463–476CrossRef

Cubells JF, Price LH, Meyers BS, Anderson GM, Zabetian CP, Alexopoulos GS, Nelson JC, Sanacora G, Kirwin P, Carpenter L, Malison RT, Gelernter J (2002) Genotype-controlled analysis of plasma dopamine beta-hydroxylase activity in psychotic unipolar major depression. Biol Psychiatry 51:358–364PubMedCrossRef

D’Amato T, Leboyer M, Malafosse A, Samolyk D, Lamouroux A, Junien C, Mallet J (1989) Two TaqI dimorphic sites at the human beta-hydroxylase locus. Nucleic Acids Res 17:5871PubMedCrossRef

Dunnette J, Weinshilboum R (1976) Human serum dopamine beta-hydroxylase: correlation of enzymatic activity with immunoreactive protein in genetically defined samples. Am J Hum Genet 28:155–166PubMed

Ehlis AC, Reif A, Herrmann MJ, Lesch KP, Fallgatter AJ (2007) Impact of catechol-O-methyltransferase on prefrontal brain functioning in schizophrenia spectrum disorders. Neuropsychopharmacology 32:162–170PubMedCrossRef

Eisemann M, Ericsson U, Von Knorring L, Perris C, Perris H, Ross S (1983) Serum dopamine-beta-hydroxylase in diagnostic subgroups of depressed patients and in relation to their personality characteristics. Neuropsychobiology 9:193–196PubMedCrossRef

Erdfelder E, Faul F, Buchner A (1996) GPOWER: a general power analysis program. Behav Res Methods Instrum Comput 28:1–11

Fahndrich E, Muller-Oerlinghausen B, Coper H (1982) Longitudinal assessment of MAO-, COMT-, and DBH- activity in patients with bipolar depression. Int Pharmacopsychiatry 17:8–17PubMed

Fichter MM, Narrow WE, Roper MT, Rehm J, Elton M, Rae DS, Locke BZ, Regier DA (1996) Prevalence of mental illness in Germany and the United States. Comparison of the Upper Bavarian Study and the Epidemiologic Catchment Area Program. J Nerv Ment Dis 184:598–606PubMedCrossRef

Freire MT, Hutz MH, Bau CH (2005) The DBH–1021 C/T polymorphism is not associated with alcoholism but possibly with patients’ exposure to life events. J Neural Transm 112:1269–1274PubMedCrossRef

Gabel S, Stadler J, Bjorn J, Shindledecker R (1995) Homovanillic acid and dopamine-beta-hydroxylase in male youth: relationships with paternal substance abuse and antisocial behavior. Am J Drug Alcohol Abuse 21:363–378PubMedCrossRef

Galvin M, Shekhar A, Simon J, Stilwell B, Ten Eyck R, Laite G, Karwisch G, Blix S (1991) Low dopamine-beta-hydroxylase: a biological sequela of abuse and neglect? Psychiatry Res 39:1–11PubMedCrossRef

Jacob CP, Strobel A, Hohenberger K, Ringel T, Gutknecht L, Reif A, Brocke B, Lesch KP (2004) Association between allelic variation of serotonin transporter function and neuroticism in anxious cluster C personality disorders. Am J Psychiatry 161:569–572PubMedCrossRef

Jacob CP, Muller J, Schmidt M, Hohenberger K, Gutknecht L, Reif A, Schmidtke A, Mossner R, Lesch KP (2005) Cluster B personality disorders are associated with allelic variation of monoamine oxidase A activity. Neuropsychopharmacology 30:1711–1718PubMedCrossRef

Jacob CP, Romanos J, Dempfle A, Heine M, Windemuth-Kieselbach C, Kruse A, Reif A, Walitza S, Romanos M, Strobel A, Brocke B, Schafer H, Schmidtke A, Boning J, Lesch KP (2007) Co-morbidity of adult attention-deficit/hyperactivity disorder with focus on personality traits and related disorders in a tertiary referral center. Eur Arch Psychiatry Clin Neurosci 257:309–317PubMedCrossRef

Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O, Faraone SV, Greenhill LL, Howes MJ, Secnik K, Spencer T, Ustun TB, Walters EE, Zaslavsky AM (2006) The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry 163:716–723PubMedCrossRef

Kobayashi K, Kurosawa Y, Fujita K, Nagatsu T (1989) Human dopamine beta-hydroxylase gene: two mRNA types having different 3′-terminal regions are produced through alternative polyadenylation. Nucleic Acids Res 17:1089–1102PubMedCrossRef

Kohnke MD, Zabetian CP, Anderson GM, Kolb W, Gaertner I, Buchkremer G, Vonthein R, Schick S, Lutz U, Kohnke AM, Cubells JF (2002) A genotype-controlled analysis of plasma dopamine beta-hydroxylase in healthy and alcoholic subjects: evidence for alcohol-related differences in noradrenergic function. Biol Psychiatry 52:1151–1158PubMedCrossRef

Kuperman S, Kramer J, Loney J (1988) Enzyme activity and behavior in hyperactive children grown up. Biol Psychiatry 24:375–383PubMedCrossRef

Lenzenweger MF, Lane MC, Loranger AW, Kessler RC (2007) DSM-IV personality disorders in the National Comorbidity Survey Replication. Biol Psychiatry 62:553–564PubMedCrossRef

Levitt M, Dunner DL, Mendlewicz J, Frewin DB, Lawlor W, Fleiss JL, Stallone F, Fieve RR (1976) Plasma dopamine beta hydroxylase activity in affective disorders. Psychopharmacologia 46:205–210PubMedCrossRef

Marino MD, Bourdelat-Parks BN, Cameron Liles L, Weinshenker D (2005) Genetic reduction of noradrenergic function alters social memory and reduces aggression in mice. Behav Brain Res 161:197–203PubMedCrossRef

Major LF, Lerner P, Goodwin FK, Ballenger JC, Brown GL, Lovenberg W (1980) Dopamine beta-hydroxylase in CSF. Relationship to personality measures. Arch Gen Psychiatry 37:308–310PubMed

Markianos ES, Nystrom I, Reichel H, Matussek N (1976) Serum dopamine-beta-hydroxylase in psychiatric patients and normals. Effect of d-amphetamine and haloperidol. Psychopharmacology (Berl) 50:259–267CrossRef

Mathew RJ, Ho BT, Davis C, Taylor D, Reck J (1981) Depression, antidepressants, and plasma DBH. Psychiatry Res 5:331–334PubMedCrossRef

Matuzas W, Meltzer HY, Uhlenhuth EH, Glass RM, Tong C (1982) Plasma dopamine-beta-hydroxylase in depressed patients. Biol Psychiatry 17:1415–1424PubMed

Meltzer HY, Cho HW, Carroll BJ, Russo P (1976) Serum dopamine-beta-hydroxylase activity in the affective psychoses and schizophrenia. Decreased activity in unipolar psychotically depressed patients. Arch Gen Psychiatry 33:585–591PubMed

Meyers BS, Alexopoulos GS, Kakuma T, Tirumalasetti F, Gabriele M, Alpert S et al (1999) Decreased dopamine beta-hydroxylase activity in unipolar geriatric delusional depression. Biol Psychiatry 45:448–452PubMedCrossRef

Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215PubMedCrossRef

Mod L, Rihmer Z, Magyar I, Arato M, Alfoldi A, Bagdy G (1986) Serum DBH activity in psychotic vs. nonpsychotic unipolar and bipolar depression. Psychiatry Res 19:331–333PubMedCrossRef

O’Connor DT, Levine GL, Frigon RP (1983) Homologous radio-immunoassay of human plasma dopamine-beta-hydroxylase: analysis of homospecific activity, circulating plasma pool and intergroup differences based on race, blood pressure and cardiac function. J Hypertens 1:227–233PubMedCrossRef

O’Connor DT, Cervenka JH, Stone RA, Levine GL, Parmer RJ, Franco-Bourland RE, Madrazo I, Langlais PJ, Robertson D, Biaggioni I (1994) Dopamine beta-hydroxylase immunoreactivity in human cerebrospinal fluid: properties, relationship to central noradrenergic neuronal activity and variation in Parkinson’s disease and congenital dopamine beta-hydroxylase deficiency. Clin Sci (Lond) 86:149–158

Oxenstierna G, Edman G, Iselius L, Oreland L, Ross SB, Sedvall G (1986) Concentrations of monoamine metabolites in the cerebrospinal fluid of twins and unrelated individuals—a genetic study. J Psychiatr Res 20:19–29PubMedCrossRef

Puzynski S, Rode A, Zaluska M (1983) Studies on biogenic amine metabolizing enzymes (DBH, COMT, MAO) and pathogenesis of affective illness. I. Plasma dopamine-beta-hydroxylase activity in endogenous depression. Acta Psychiatr Scand 67:89–95PubMedCrossRef

Reif A, Lesch KP (2003) Toward a molecular architecture of personality. Behav Brain Res 139:1–20PubMedCrossRef

Rogeness GA, Hernandez JM, Macedo CA, Mitchell EL (1982) Biochemical differences in children with conduct disorder socialized and undersocialized. Am J Psychiatry 139:307–311PubMed

Roy A, Brockington K (1987) Plasma dopamine-beta-hydroxylase in depressed patients and controls. Neuropsychobiology 18:57–59PubMedCrossRef

Sapru MK, Rao BS, Channabasavanna SM (1989) Serum dopamine-beta-hydroxylase activity in clinical subtypes of depression. Acta Psychiatr Scand 80:474–478PubMedCrossRef

Sofuoglu S, Dogan P, Kose K, Esel E, Basturk M, Oguz H, Gonul AS (1995) Changes in platelet monoamine oxidase and plasma dopamine-beta-hydroxylase activities in lithium-treated bipolar patients. Psychiatry Res 59:165–170PubMedCrossRef

Strandman E, Wetterberg L, Perris C, Ross SB (1978) Serum dopamine-beta-hydroxylase in affective disorders. Neuropsychobiology 4:248–255PubMedCrossRef

Tang Y, Anderson GM, Zabetian CP, Kohnke MD, Cubells JF (2005) Haplotype-controlled analysis of the association of a non-synonymous single nucleotide polymorphism at DBH (+1603C → T) with plasma dopamine beta-hydroxylase activity. Am J Med Genet B Neuropsychiatr Genet 139:88–90

Tang Y, Buxbaum SG, Waldman I, Anderson GM, Zabetian CP, Kohnke MD, Cubells JF (2006) A single nucleotide polymorphism at DBH, possibly associated with attention-deficit/hyperactivity disorder, associates with lower plasma dopamine beta-hydroxylase activity and is in linkage disequilibrium with two putative functional single nucleotide polymorphisms. Biol Psychiatry 60(10):1034–1038PubMedCrossRef

Thomas SA, Palmiter RD (1997) Disruption of the dopamine beta-hydroxylase gene in mice suggests roles for norepinephrine in motor function, learning, and memory. Behav Neurosci 111:579–589PubMedCrossRef

Zabetian CP, Anderson GM, Buxbaum SG, Elston RC, Ichinose H, Nagatsu T, Kim KS, Kim CH, Malison RT, Gelernter J, Cubells JF (2001) A quantitative-trait analysis of human plasma-dopamine beta-hydroxylase activity: evidence for a major functional polymorphism at the DBH locus. Am J Hum Genet 68:515–522PubMedCrossRef

Zabetian CP, Buxbaum SG, Elston RC, Kohnke MD, Anderson GM, Gelernter J, Cubells JF (2003) The structure of linkage disequilibrium at the DBH locus strongly influences the magnitude of association between diallelic markers and plasma dopamine beta-hydroxylase activity. Am J Hum Genet 72:1389–1400PubMedCrossRef

Zhang HB, Wang YF, Li J, Wang B, Yang L (2005) Association between dopamine beta hydroxylase gene and attention deficit hyperactivity disorder complicated with disruptive behavior disorder. Zhonghua Er Ke Za Zhi 43:26–30PubMed

Zuckerman M (1993) P-impulsive sensation seeking and its behavioral, psychophysiological and biochemical correlates. Neuropsychobiology 28:30–36PubMedCrossRef

Title: A functional dopamine-β-hydroxylase gene promoter polymorphism is associated with impulsive personality styles, but not with affective disorders
Authors: C. Hess
A. Reif
A. Strobel
A. Boreatti-Hümmer
M. Heine
K.-P. Lesch
C. P. Jacob
Publication date: 01-02-2009
Publisher: Springer Vienna
Published in: Journal of Neural Transmission / Issue 2/2009
Print ISSN: 0300-9564
Electronic ISSN: 1435-1463
DOI: https://doi.org/10.1007/s00702-008-0138-0

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

A functional dopamine-β-hydroxylase gene promoter polymorphism is associated with impulsive personality styles, but not with affective disorders

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2009

Acquired stuttering after pallidal deep brain stimulation for dystonia

Encephalitis lethargica and influenza. I. The role of the influenza virus in the influenza pandemic of 1918/1919

Combined CSF tau, p-tau181 and amyloid-β 38/40/42 for diagnosing Alzheimer’s disease

Risk of valvular heart disease associated with the use of dopamine agonists in Parkinson’s disease: a systematic review

MEG resting state functional connectivity in Parkinson’s disease related dementia

Differentiating nicotine- versus schizophrenia-associated decreases of the α7 nicotinic acetylcholine receptor transcript, CHRFAM7A, in peripheral blood lymphocytes